Leerink Partners Raises PT on Intuitive Surgical, Maintains Buy Rating
PorAinvest
jueves, 7 de agosto de 2025, 12:44 pm ET1 min de lectura
ISRG--
Intuitive Surgical reported revenue of $2.44 billion for the quarter, up 21% year-over-year, with a 17% increase in procedure volumes and record placements of 395 da Vinci systems globally. The da Vinci 5 systems, which received EU certification for adult and pediatric procedures, were particularly notable, with 180 systems placed, up from 70 a year earlier. The total installed base expanded to 10,488 systems, a 14% increase [2].
The company also updated its 2025 gross margin outlook to 66%, adjusting for tariff effects, and reaffirmed expectations for 15–17% global procedure growth this year, reflecting strong demand as hospitals address surgical backlogs and broaden access to robotic procedures [2].
Leerink Partners' analysts noted that the company's growth is driven by its leadership in robotic-assisted, minimally invasive surgery, and the increasing adoption of its da Vinci systems. The firm also raised its full-year guidance for procedure growth and gross margin, reflecting the company's continued innovation and market leadership.
Intuitive Surgical's strong performance in Q2 2025 underscores its position as a global technology leader in robotic-assisted, minimally invasive surgery. The company's focus on innovation, such as the da Vinci 5 systems, and its ability to adapt to changing market conditions have positioned it well for future growth.
References:
[1] https://isrg.intuitive.com/
[2] https://finance.yahoo.com/news/intuitive-surgical-inc-isrg-installs-151004972.html
Leerink Partners raised their price target for Intuitive Surgical (ISRG) to $593, maintaining a Buy rating. The company reported strong Q2 2025 results, with revenue and EPS exceeding expectations. Robust growth in all segments and increased da Vinci system placements in the US drove the results. The firm also raised its full-year guidance for procedure growth and gross margin.
Leerink Partners has raised its price target for Intuitive Surgical (ISRG) to $593, maintaining a Buy rating following the company's robust Q2 2025 results. The report highlights strong revenue and EPS growth, driven by robust demand for Intuitive's da Vinci robotic surgical systems.Intuitive Surgical reported revenue of $2.44 billion for the quarter, up 21% year-over-year, with a 17% increase in procedure volumes and record placements of 395 da Vinci systems globally. The da Vinci 5 systems, which received EU certification for adult and pediatric procedures, were particularly notable, with 180 systems placed, up from 70 a year earlier. The total installed base expanded to 10,488 systems, a 14% increase [2].
The company also updated its 2025 gross margin outlook to 66%, adjusting for tariff effects, and reaffirmed expectations for 15–17% global procedure growth this year, reflecting strong demand as hospitals address surgical backlogs and broaden access to robotic procedures [2].
Leerink Partners' analysts noted that the company's growth is driven by its leadership in robotic-assisted, minimally invasive surgery, and the increasing adoption of its da Vinci systems. The firm also raised its full-year guidance for procedure growth and gross margin, reflecting the company's continued innovation and market leadership.
Intuitive Surgical's strong performance in Q2 2025 underscores its position as a global technology leader in robotic-assisted, minimally invasive surgery. The company's focus on innovation, such as the da Vinci 5 systems, and its ability to adapt to changing market conditions have positioned it well for future growth.
References:
[1] https://isrg.intuitive.com/
[2] https://finance.yahoo.com/news/intuitive-surgical-inc-isrg-installs-151004972.html

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios